Cambridge Capital Group angels enjoy four exits in 2016

Four portfolio companies have achieved trade sales or mergers in 2016, giving strong returns to our members: Swiftkey (Touchtype) sold to Microsoft for $250m, Cambridge CMOS Sensors sold to Austrian Microsystems, Expedeon merged with quoted Sygnis; and Oval Medical Technologies has been sold to SMC. (CCG was the first angel group pitched to by Oval in 2010 and we supported subsequent rounds through to exit this month.)

Cambridge Capital Group, the first private business angel network in Cambridge, has also invested £2.5 million in early-stage technology companies during the first nine months of 2016, mainly through the EIS scheme. Members of the group have committed capital in a number of new and portfolio deals across different sectors including Artificial Intelligence, Medtech, Semiconductors, Genomics and the Internet of Things. Our angels have continued to display an interest in technology companies both across the Cambridge Cluster and further afield to London and Oxford, (the “golden triangle”).

Investment in the UK’s high-growth companies has more than doubled over the past four years, investor interest in the asset class continues to grow and Britain is beginning to display an ability to build highly scalable companies. Cambridge Capital Group continues to sustain an active role in the high-growth ecosystem providing our members with exciting deal flow and a collaborative investment process.